Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497667/ https://www.ncbi.nlm.nih.gov/pubmed/37556006 http://dx.doi.org/10.1007/s10067-023-06727-0 |
_version_ | 1785105355668193280 |
---|---|
author | Chen, Fangfang Lang, Yitian Geng, Shikai Wang, Xiaodong Lu, Liangjing Ye, Shuang Zhang, Le Li, Ting |
author_facet | Chen, Fangfang Lang, Yitian Geng, Shikai Wang, Xiaodong Lu, Liangjing Ye, Shuang Zhang, Le Li, Ting |
author_sort | Chen, Fangfang |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10497667 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-104976672023-09-14 Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis Chen, Fangfang Lang, Yitian Geng, Shikai Wang, Xiaodong Lu, Liangjing Ye, Shuang Zhang, Le Li, Ting Clin Rheumatol Correction Springer International Publishing 2023-08-09 2023 /pmc/articles/PMC10497667/ /pubmed/37556006 http://dx.doi.org/10.1007/s10067-023-06727-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correction Chen, Fangfang Lang, Yitian Geng, Shikai Wang, Xiaodong Lu, Liangjing Ye, Shuang Zhang, Le Li, Ting Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis |
title | Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis |
title_full | Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis |
title_fullStr | Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis |
title_full_unstemmed | Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis |
title_short | Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis |
title_sort | correction to: the effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497667/ https://www.ncbi.nlm.nih.gov/pubmed/37556006 http://dx.doi.org/10.1007/s10067-023-06727-0 |
work_keys_str_mv | AT chenfangfang correctiontotheeffectivethresholddoseofetanerceptinpatientswithmethotrexateresistantrheumatoidarthritis AT langyitian correctiontotheeffectivethresholddoseofetanerceptinpatientswithmethotrexateresistantrheumatoidarthritis AT gengshikai correctiontotheeffectivethresholddoseofetanerceptinpatientswithmethotrexateresistantrheumatoidarthritis AT wangxiaodong correctiontotheeffectivethresholddoseofetanerceptinpatientswithmethotrexateresistantrheumatoidarthritis AT luliangjing correctiontotheeffectivethresholddoseofetanerceptinpatientswithmethotrexateresistantrheumatoidarthritis AT yeshuang correctiontotheeffectivethresholddoseofetanerceptinpatientswithmethotrexateresistantrheumatoidarthritis AT zhangle correctiontotheeffectivethresholddoseofetanerceptinpatientswithmethotrexateresistantrheumatoidarthritis AT liting correctiontotheeffectivethresholddoseofetanerceptinpatientswithmethotrexateresistantrheumatoidarthritis |